首页> 外文会议>World biomaterials congress >Inhibition of RGD-modified composite nerve conduit on traumatic neuroma formation
【24h】

Inhibition of RGD-modified composite nerve conduit on traumatic neuroma formation

机译:RGD修饰的复合神经导管对创伤性神经瘤形成的抑制作用

获取原文

摘要

Peripheral nerve injury is the common cause that leads to disability. Large nerve defect and traumatic neuroma are two main bottleneck problems during repairing after peripheral nerve injury. So far, the mechanism of neuroma development and progression are still unclear, and there is very limited research on neuroma inhibition with nerve conduit. Our group previously found that a PDLLA/PRGD/β-TCP composite conduit had beneficial effect on nerve regeneration, and no obvious neuroma formation was found in around 300 experimental animals. The main mechanism of neuroma formation is based on excessively sedimentary collagen proliferation. We hypothesize that POLLA/PRGD/β-TCP composite have the effect on the neural scar formation-related cytokines such as NGF, IFN-y etc., matrix metallo-proteinases, gene expression and protein level of collagen. The effect of the conduit on neural scar distribution and scar ratio, nerve function recovery, structure of regenerated myelin sheath have been studied. In vitro test, PRGD/PDLLA/β-TCP membranes showed better cytocompatibility with Schwann cells. Testing in vivo demonstrated that PRGD/PDLLA/β-TCP conduits can effectively promote axonal regeneration of 10mm rat sciatic nerve defect, which is close to the success of autograft. After an observation period of 1 month, PRGD/PDLLA/β-TCP conduit-implanted showed no neuroma and significantly improving on the neurophysiological and neuropathological levels compared with the PDLLA conduit as control group. The microenvironment of the inner conduit, containing an appropriate concentration of calcium ion, growth factors and immunologic factors, played an important role in the inhibition of neuroma formation. The neural scar distribution is perineural scarring and the scar ratio is lower than the control of PDLLA group. The study revealed that PRGD/PDLLA/β-TCP conduits promoted nerve regeneration and inhibits neuroma formation. It is going to provide experimental basis for future studies in nerve conduits for inhibition of neuroma formation and promoting long-distance nerve regeneration as well as the clinical therapy for neuroma.
机译:周围神经损伤是导致残疾的常见原因。大神经缺损和创伤性神经瘤是周围神经损伤修复过程中的两个主要瓶颈问题。迄今为止,神经瘤的发生和发展的机制仍不清楚,关于神经导管对神经瘤的抑制的研究非常有限。我们的小组先前发现,PDLLA / PRGD /β-TCP复合导管对神经再生具有有益作用,并且在大约300只实验动物中未发现明显的神经瘤形成。神经瘤形成的主要机制是基于过度沉积的胶原蛋白增殖。我们假设POLLA / PRGD /β-TCP复合物对神经瘢痕形成相关的细胞因子如NGF,IFN-γ等,基质金属蛋白酶,基因表达和胶原蛋白水平有影响。研究了导管对神经瘢痕分布和瘢痕比例,神经功能恢复,髓鞘再生结构的影响。在体外试验中,PRGD / PDLLA /β-TCP膜表现出与雪旺氏细胞更好的细胞相容性。体内测试表明PRGD / PDLLA /β-TCP导管可有效促进10mm大鼠坐骨神经缺损的轴突再生,接近自体移植的成功。 1个月的观察期后,与对照组相比,植入PRGD / PDLLA /β-TCP导管无神经瘤,神经生理和神经病理水平明显改善。内管的微环境包含适当浓度的钙离子,生长因子和免疫因子,在抑制神经瘤形成中起着重要作用。神经瘢痕分布为神经周围瘢痕,并且瘢痕比率低于PDLLA组的对照组。研究表明,PRGD / PDLLA /β-TCP导管可促进神经再生并抑制神经瘤的形成。这将为今后神经导管抑制神经瘤形成,促进远距离神经再生以及神经瘤的临床治疗提供实验依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号